Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
Sangivamycin |
EINECS | N/A |
CAS No. | 18417-89-5 | Density | 1.3120 (rough estimate) |
PSA | 178.97000 | LogP | -1.05890 |
Solubility | N/A | Melting Point |
260°C |
Formula | C12H15N5O5 | Boiling Point | 880.6°C at 760 mmHg |
Molecular Weight | 309.32 | Flash Point | 486.4°C |
Transport Information | N/A | Appearance | N/A |
Safety | Poison by ingestion, intravenous and intraperitoneal routes. Human mutation data reported. When heated to decomposition it emits toxic fumes of NOx. | Risk Codes | R26/27/28 |
Molecular Structure | Hazard Symbols | T+ | |
Synonyms |
7-DEAZA-7-CARBAMOYLADENOSINE;7-Carboxamido-7-deazaadenosine;7-DEAZAADENOSINE-7-CARBOXAMIDE;SANGIVAMYCIN; |
Article Data | 11 |
Empirical Formula of Sangivamycin (CAS NO.18417-89-5): C12H15N5O5
Molecular Weight: 309.278 g/mol
Index of Refraction: 1.886
Density: 2.06 g/cm3
Flash Point: 443.9 °C
Enthalpy of Vaporization: 123.52 kJ/mol
Boiling Point: 810.4 °C at 760 mmHg
Vapour Pressure: 9.5E-28 mmHg at 25 °C
Structure of Sangivamycin (CAS NO.18417-89-5):
IUPAC Name: 4-Amino-7-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidine-5-carboxamide
Canonical SMILES: C1=C(C2=C(N1C3C(C(C(O3)CO)O)O)N=CN=C2N)C(=O)N
Isomeric SMILES: C1=C(C2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N=CN=C2N)C(=O)N
InChI: InChI=1S/C12H15N5O5/c13-9-6-4(10(14)21)1-17(11(6)16-3-15-9)12-8(20)7(19)5(2-18)22-12/h1,3,5,7-8,12,18-20H,2H2,(H2,14,21)(H2,13,15,16)/t5-,7-,8-,12-/m1/s1
InChIKey: OBZJZDHRXBKKTJ-JTFADIMSSA-N
1. | dni-hmn:hla 20 mg/L | JANTAJ Journal of Antibiotics. 35 (1982),119. | ||
2. | oms-hmn:hla 20 mg/L | JANTAJ Journal of Antibiotics. 35 (1982),119. | ||
3. | oms-mus:leu 10 µmol/L | BCPCA6 Biochemical Pharmacology. 29 (1980),305. | ||
4. | ipr-rat LDLo:1200 µg/kg | NCINS* National Cancer Institute Report .(Bethesda, MD.: )1967,269. | ||
5. | orl-mus LD50:11 mg/kg | NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program, Bethesda, MD 20205 JAN86 . | ||
6. | ipr-mus LDLo:4 mg/kg | NCINS* National Cancer Institute Report .(Bethesda, MD.: )1967,269. | ||
7. | ivn-mus LD50:5 mg/kg | 85GDA2 CRC Handbook of Antibiotic Compounds, Volumes 1-9. 5 (1981),313. |
Poison by ingestion, intravenous and intraperitoneal routes. Human mutation data reported. When heated to decomposition it emits toxic fumes of NOx.
Hazard Codes of Sangivamycin (CAS NO.18417-89-5): T+
Risk Statements: 26/27/28
R26/27/28:Very toxic by inhalation, in contact with skin and if swallowed.
Safety Statements: 36/37/39-45
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection.
S45:In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
Sangivamycin , its cas register number is 18417-89-5. It also can be called Ara-sangivamycin ; 4-Amino-7-beta-D-ribofuranosyl-7H-pyrrolo(2,3-d)pyrimidine-5-carboxamide ; and 7H-Pyrrolo(2,3-d)pyrimidine-5-carboxamide, 4-amino-7-beta-D-ribofuranosyl- .